🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial evaluates whether early switching from modified fluorou...
Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Start Date
2021-05-27
Trial ID
NCT04539808
This clinical study is in subjects who are 18 years old or older with local...
Status
Completed
Location
Mayo Clinic - Arizona
Start Date
2015-04-21
Trial ID
NCT02301143
Treatments Being Tested
We want to compare Taxol given weekly with Taxotere given every 3 week both...
Status
Completed
Location
Ullevål university hospital
Start Date
2005-03
Trial ID
NCT00201435
This study is designed to evaluate the efficacy and safety of first-line tr...
Status
Completed
Location
Gemeinschaftspraxis für Hämatologie und Onkologie
Start Date
2018-05-24
Trial ID
NCT03462251
The safety and efficacy of pembrolizumab plus the investigator's choice of ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham-Medicine ( Site 0065)
Start Date
2021-06-18
Trial ID
NCT04895358
Treatments Being Tested
This randomized phase III trial studies carboplatin given together with pac...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2010-10-12
Trial ID
NCT01081262
The purpose of this study is to determine whether * Paclitaxel and bevaciz...
Status
Terminated
Location
GBG Forschungs GmbH
Start Date
2009-07
Trial ID
NCT01200212
Treatments Being Tested
This is a Phase III, multicenter, randomized, placebo-controlled trial desi...
Status
Unknown
Location
Multiple Locations
Start Date
2005-12
Trial ID
NCT00262067
Treatments Being Tested
Observational investigation of participants who are given neoadjuvant treat...
Status
Not Yet Recruiting
Location
National Institute of Oncolgy
Start Date
2022-03
Trial ID
NCT05131893
AMBRE is a phase III study comparing two standard treatments as initial met...
Status
Active Not Recruiting
Location
Centre Hospitalier Lyon Sud
Start Date
2020-06-11
Trial ID
NCT04158362